Trial
NCT01280643
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Metastatic Colorectal Cancer
Intervention
fluorouracil
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-15